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Abstract
The use of tamoxifen (TAM) has been questioned on the chemotherapy and chemoprevention of breast cancer due to
several estrogen receptor-independent cytotoxic effects. As an alternative, its more active metabolite 4-hydroxytamox-
ifen (OHTAM) has been proposed with presumed lower side effects. In this work, the potential OHTAM toxicity on rat
liver mitochondrial bioenergetics in relation to the multiple deleterious effects of TAM was evaluated. OHTAM, at
concentrations lower than those putatively reached in tissues following the administration of TAM, does not induce
significant perturbations on the respiratory control ratio (RCR), ADP/O, transmembrane potential (DC), phosphor-
ylative capacity and membrane integrity of mitochondria. However, at high concentrations, OHTAM depresses the
DC, RCR and ADP/O, affecting the phosphorylation efficiency, as also inferred from the DC fluctuations and pH
changes associated with ADP phosphorylation. Moreover, OHTAM, at concentrations that stimulate the rate of state 4
respiration in parallel to the decrease in the DC and phosphorylation rate, causes mitochondrial swelling and stimulates
both ATPase and citrate synthase activities. However, the OHTAM-observed effects, at high concentrations, are not
significant relatively to the damaging effects promoted by TAM and suggest alterations to mitochondrial functions due
to proton leak across the mitochondrial inner membrane. # 2002 Elsevier Science Ireland Ltd. All rights reserved.
Keywords: 4-Hydroxytamoxifen; Breast cancer; Mitochondrial bioenergetics; Mitochondrial transmembrane potential; Oxidative
phosphorylation efficiency; Proton leak; Membrane permeabilization
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ether) NNN?N-tetraacetic acid; FCCP, carbonyl cyanide p -trifluormethoxyphenylhydrazone; HEPES, 4-(2-hydroxymethyl)-1-
piperazineethanesulfonic acid; Mops, 3-[N -Morpholino]propanesulfonic acid; OHTAM, 4-hydroxytamoxifen; RCR, respiratory
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1. Introduction
Tamoxifen (TAM) is an important adjunct
chemotherapeutic agent for treating breast cancer
(Early Breast Cancer Trialists’ Collaborative
Group, 1998). This non-steroidal antiestrogen
has also been reported as an effective agent in
the chemoprevention of healthy women at high
risk of the disease (Ault and Brandbury, 1998).
However, TAM causes serious side effects, such as
hepatocellular damage and agranulocytosis (Ching
et al., 1992), increased risk of uterine and endo-
metrial cancers (Ault and Brandbury 1998; Early
Breast Cancer Trialists’ Collaborative Group,
1998), hemolytic anemia (Ching et al., 1992;
Suwalsky et al., 1998), inhibition of Ca2 uptake
by sarcoplasmic reticulum (SR) (Custo´dio et al.,
1996; Kargacin et al., 2000) and erythrocyte
hemolysis (Cruz Silva et al., 2000). Therefore, an
alternative breast cancer treatment with presumed
lower side effects, such as the percutaneous
administration of 4-hydroxytamoxifen (OHTAM),
the major active metabolite of TAM and respon-
sible for its antiestrogenic activity, has already
been performed (Mauvais-Jarvis et al., 1986).
Previous studies have reported that, in compar-
ison with TAM, OHTAM has higher affinity and
specificity for the estrogen receptor (ER) (Borgna
and Rochefort, 1981) and, besides being 100- to
200- times more potent (Osborne et al., 1992;
Jordan et al., 1988), it is pharmacologically well
tolerated (Sauvez et al., 1999) and less toxic to
erythrocytes (Cruz Silva et al., 2001) and to the SR
calcium pump (Custo´dio et al., 1996). Further-
more, in contrast to TAM, OHTAM fails to
induce either mitochondrial depolarization or
caspase activation and, subsequently, does not
induce apoptosis in p53(/) human mammary
epithelial cells [p53(/)HMEC] (Dietze et al.,
2001). Despite these and other studies, including
those reporting the differences between the OH-
TAM percutaneous and oral administration (Pujol
et al., 1995; Sauvez et al., 1999), the toxicity
mechanisms of OHTAM are not yet clarified.
Therefore, toxicological studies are required to
assure a safe and appropriate administration of
OHTAM on breast cancer therapy and to achieve
a better understanding of the molecular pharma-
cology of this drug.
Mitochondria are important subcellular sites
recognized as energy generators for the cell, as
well as control points of cell replication, differ-
entiation, ion regulation and other active transport
processes of intermediary metabolism (Wallace et
al., 1997; Wallace and Starkov, 2000). Moreover,
recent studies have demonstrated that mitochon-
dria play a key role in cell signaling and in the
apoptotic cell death (Loeffler and Kroemer, 2000).
Consequently, changes in the structural and func-
tional characteristics of mitochondria provide a
number of primary targets for xenobiotic-induced
toxicity and cell death (Wallace and Starkov,
2000). Therefore, in addition to the different
effects reported for TAM and its metabolite
OHTAM on mitochondria structure and apopto-
sis of p53(/)HMEC cells (Dietze et al., 2001), the
evaluation of OHTAM effects on mitochondrial
bioenergetic functions are important to a better
understanding of its molecular action mechanisms
and potential mitochondrial toxicity in relation to
the damaging effects of TAM (Cardoso et al.,
2001).
2. Materials and methods
2.1. Chemicals
OHTAM, bovine serum albumin (BSA), 4-(2-
hydroxymethyl)-1-piperazineethanesulfonic acid
(HEPES), ethylene glycol-bis (b-aminoethyl ether)
NNN?N-tetraacetic acid (EGTA), 3-[N -Morpho-
lino]propanesulfonic acid (Mops), 5,5?-dithio-
bis(2-nitrobenzoic acid), oxaloacetic acid, acetyl-
coA, nigericin and oligomycin were purchased
from Sigma Chemical Co (St. Louis, MO). Tris
(hydroxymethyl)-aminomethan (Tris), tetraphe-
nylphosphonium (TPP), carbonyl cyanide p-
trifluormethoxyphenylhydrazone (FCCP) and su-
crose were obtained from Merck (Dramstadt,
Germany). All other chemicals were commercial
products of the highest purity grade available and
solutions were prepared in deionized ultra pure
water.
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2.2. Preparation of rat liver mitochondria
Mitochondria were isolated from the liver of
overnight fasted Wistar rats (250/300 g) of either
sex by differential centrifugation as described
elsewhere (Custo´dio et al., 1998), with slight
modifications. Animals were killed by decapitation
and the liver was quickly homogenized. The
homogenate was prepared in 250 mM sucrose, 10
mM HEPES (pH 7.4), 1 mM EGTA and 0.1% (w/
v) free fatty acid BSA. The liver homogenate was
centrifuged at 500/g for 10 min at 4 8C and
mitochondria were recovered from the supernatant
by centrifugation at 10 000/g for 10 min. The
mitochondrial pellet was resuspended twice in the
washing medium containing 250 mM sucrose, 10
mM HEPES, pH 7.2. Mitochondrial protein was
determined by the biuret method using BSA as the
standard (Gornall et al., 1949).
2.3. Mitochondrial membrane potential
measurements
Mitochondrial membrane potential (DC) was
estimated by calculating transmembrane distribu-
tion of TPP with a TPP-selective electrode
prepared according to Kamo et al. (1979), using a
Ag/AgCl-saturated electrode as reference (model
MI 402; Microelectrodes, Inc., Bedford, NH). DC
is expressed in mV and TPP uptake was mea-
sured from the decreased TPP concentration in
the medium sensed by the electrode. The differ-
ences between the selective and the reference
electrodes were measured with an electrometer
and were recorded continuously (Kamo et al.,
1979; Moreno and Madeira, 1991). Reactions were
carried out in a closed chamber at 25 8C, with
magnetic stirring in 1 ml of standard respiratory
medium (130 mM sucrose, 50 mM KCl, 2.5 mM
MgCl2, 2.5 mM KH2PO4, 5 mM HEPES and 0.1
mM EGTA) supplemented with 2 mM rotenone
and 4 mM TPP. OHTAM was added from
ethanolic solutions to mitochondria (1 mg) and
pre-incubated for 3 min before the addition of 5
mM succinate to ensure the complete incorpora-
tion of the compound into the membrane due to its
lipophilic characteristics (Custo´dio et al., 1991).
After reaching a steady-state distribution of
TPP, ADP (150 nmol/mg protein) was added.
Preliminary calibrations run in the presence of
OHTAM excluded any direct interference of the
drug with the electrode signal.
2.4. Mitochondrial respiration
The oxygen consumption (respiration rate) of
isolated mitochondria was measured polarogra-
phically using a Clark-type oxygen electrode (YSI
model 5331, Yellow Spring Inst.), in a 1 ml
thermostated water-jacketed closed chamber with
magnetic stirring and connected to a suitable
recorder. OHTAM in ethanolic solutions (up to
3 ml) was incubated for 3 min at 25 8C in 1 ml of
the standard respiratory medium previously sup-
plemented with mitochondria (1 mg) and 2 mM
rotenone. State 4 respiration was initiated with 5
mM succinate and ADP (150 nmol/mg protein)
was added to establish state 3 respiration. Respira-
tion rates were calculated assuming an oxygen
concentration of 240 nmol O2/ml in the experi-
mental medium at 25 8C. Respiratory control
ratio (RCR/state 3/state 4), respiratory rates,
and ADP/O ratios (number of ADP molecules
added to the medium per oxygen atom consumed
during phosphorylation) were calculated accord-
ing to Chance and Williams (1956).
2.5. Simultaneous measurements of respiration rate
and DC
In order to determine the effects of OHTAM on
mitochondrial function and to discriminate its site
of action on mitochondria we adopted the ap-
proach commonly used for top/down metabolic
control analysis (Brand, 1990; Hafner et al., 1990;
Lionetti et al., 1998). With this approach, oxida-
tive phosphorylation is conceptually divided into
three subsystems, i.e., mitochondrial respiratory
chain, phosphorylation system and the proton
leak. To assess the effects of OHTAM on the
proton motive force (Dp ) producing system (the
respiratory chain complexes and the substrate
transporters), mitochondrial respiration and DC
were measured simultaneously at 25 8C in a 1-ml
incubation chamber fitted with a Clark-type oxy-
gen electrode and a TPP sensitive electrode.
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Mitochondria (1 mg) were suspended in the
reaction medium containing 130 mM sucrose,
100 mM KCl, 2.5 mM MgCl2, 2.5 mM KH2PO4,
5 mM HEPES and 0.1 mM EGTA, supplemented
with 2 mM rotenone, 4 mM TPP, 1 mg oligomycin
(to eliminate phosphorylation) and 50 ng nigericin,
which was used to collapse the pH gradient across
the mitochondrial inner membrane (Murphy and
Brand, 1987; Hafner and Brand, 1991), making the
DC the sole component of Dp . Mitochondria were
incubated under these conditions for 3 min in the
presence of OHTAM. Respiration was initiated by
the addition of 5 mM succinate and after a steady-
state TPP distribution the titration was per-
formed by successive additions of FCCP (10
nM), according to previously described procedures
(Brand, 1990; Lionetti et al., 1998). The same
protocol was followed to assess the effects of
OHTAM on proton leak (i.e. the passive perme-
ability of the inner mitochondrial membrane to
protons and any cation cycling reactions), but the
titration was done with successive additions of
malonate (0.5 mM). Titration experiments with
OHTAM were conducted under similar conditions
in the absence of either FCCP or malonate.
2.6. Measurement of mitochondrial swelling
Mitochondrial osmotic volume changes were
followed by monitoring the decrease in absorbance
(light-scattering) at 540 nm (Custo´dio et al., 1998)
with a Perkin Elmer, Lambda 6 UV/VIS spectro-
photometer. The reactions were performed with 1
mg mitochondrial protein in 2 ml of a reaction
medium containing 200 mM sucrose, 10 mM Tris-
Mops (pH 7.4), 1 mM KH2PO4 and 10 mM
EGTA. OHTAM and TAM were added to mito-
chondrial suspensions in the absence of respiratory
substrates and preincubated for 3 min at 30 8C.
2.7. Enzymatic activities
ATPase activity was estimated by monitoring
the pH changes of the medium associated with
ATP hydrolysis (Madeira et al., 1974). The experi-
ments were carried out at 25 8C in 2 ml of the
standard respiratory medium lightly buffered con-
taining 0.5 mM HEPES, 130 mM sucrose, 50 mM
KCl, 2.5 mM MgCl2, 5 mM KH2PO4, 0.1 mM
EGTA, pH 7.2 and supplemented with 2 mM
rotenone. OHTAM and TAM were incubated
with mitochondria (1 mg) for 3 min before starting
the reactions with Mg-ATP as described elsewhere
(Ferreira et al., 1997). Oligomycin (1 mg/mg
protein) was added 1.5 min after starting the
reactions.
ATP-synthase activity was determined by mea-
suring the pH changes of the medium associated
with ATP synthesis as reported by Moreno and
Madeira (1991), at 25 8C, in 2 ml of reaction
medium containing 130 mM sucrose, 50 mM KCl,
2.5 mM MgCl2, 5 mM KH2PO4, 0.5 mM HEPES,
0.1 mM EGTA, pH 7.2, supplemented with 2 mM
rotenone, 100 mM ADP and mitochondria (1 mg).
The experiments were initiated by the addition of 5
mM succinate. TAM and OHTAM, in ethanolic
solutions, were added and allowed to incubate
with mitochondria for 3 min before starting the
reactions.
Citrate synthase activity was monitored by the
increase in absorbance at 412 nm as previously
described (Shepherd and Garland, 1969; Trounce
et al., 1996), using a Perkin Elmer, Lambda 6 UV/
VIS spectrophotometer. The reactions were per-
formed with 100 mg of mitochondrial protein
suspended in 2 ml of the reaction medium contain-
ing 100 mM Tris (pH 8), 200 mM 5,5?-dithio-bis(2-
nitrobenzoic acid) and 200 mM acetylCoA. The
assays were started by the addition of 100 mM
oxaloacetic acid after incubation of mitochondria
in the absence and presence of either 0.1% Triton
X-100, TAM or OHTAM for 3 min at 30 8C.
3. Results
To assess whether OHTAM affects mitochon-
drial bioenergetic functions, we evaluated the
respiration parameters, both the RCR and ADP/
O ratio (Fig. 1), and the DC (Fig. 2) of mitochon-
dria energized with succinate. OHTAM pre-incu-
bated with mitochondria progressively decreases
RCR and ADP/O ratios as a function of concen-
tration (Fig. 1). However, both ratios are not
significantly affected by OHTAM as opposed to
the high decrease observed at much lower concen-
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trations of TAM (Cardoso et al., 2001). Addition-
ally, OHTAM at concentrations up to 70 nmol/mg
protein does not yet induce complete uncoupling
of mitochondria (Figs. 1 and 2). In contrast, TAM
induces such drastic effect at 40 nmol TAM/mg
protein (Cardoso et al., 2001), suggesting that
OHTAM is much less toxic to mitochondrial
membrane than TAM.
The effects of several concentrations of OHTAM
on DC fluctuations associated with either the
mitochondrial respiration or the phosphorylation
cycle induced by ADP are shown in Fig. 2. Under
succinate energization, mitochondria build up a
potential of about/220 mV (negative inside). Upon
ADP addition (150 nmol/mg protein), to initiate
state 3 respiration (synthesis of ATP), the potential
drops immediately to /190 mV, since the phos-
phorylation system consumes DC to transport and
to phosphorylate ADP. After a short lag phase,
when the phosphorylation cycle is completed, the
transmembrane potential returns to nearly its initial
value. OHTAM, at concentrations lower than those
putatively reached in tissues following the admin-
istration of TAM (McCague et al., 1990; Jordan,
1990; Lien et al., 1991), slightly depresses theDCand
the depolarization after ADP addition. However, at
high concentrations (/40 nmol/mg protein), the lag
phase preceding repolarization displays a marked
increase and the rate of repolarization progressively
decreases (Fig. 2), suggesting that OHTAM affects
the efficiency of the mitochondrial phosphorylative
system. These effects become more pronounced at
higher OHTAM concentrations whereas TAM, at
much lower concentrations, induces a drastic
depolarization of DC and total uncoupling of
mitochondria, making them unable to phosphor-
ylate the added ADP (Cardoso et al., 2001). This is
evidenced in Fig. 3 that shows the effects of both
drugs on pH changes associated with ATP synthesis.
Thus, the consequences of OHTAM on the
phosphorylation cycle induced by ADP, as shown
in Fig. 2, are consistent with those on ADP/O ratio
(Fig. 1) and with the promoted decrease in the rate of
ATP synthesis by intact mitochondria (Fig. 3). In
fact, increasing concentrations of OHTAM depress
the rate of ATP synthesis, increasing the time
required to phosphorylate the ADP (200 nmol/mg
protein) (Fig. 3). However, it is noteworthy that
TAM, at a concentration of 50 nmol/mg protein,
completely inhibits the phosphorylation of the
added ADP, in contrast to OHTAM that at the
same concentration only decreases the rate of
phosphorylation (Fig. 3).
A simultaneous follow-up of OHTAM effects
on both DC and state 4 respiration (Fig. 4) shows
that sequential additions of this drug to mitochon-
dria causes a small decrease in DC and a parallel
stimulation of state 4 respiration to compensate
the induced depolarization of DC. Subsequent
additions of OHTAM lead to a lower stimulation
of respiration rate, concomitantly with a signifi-
cant depolarization of DC (results not shown).
In agreement with the depolarization of DC
(Fig. 2) and the stimulation of state 4 (Fig. 4)
caused by a proton leak through the mitochondrial
inner membrane, OHTAM increases the ATPase
activity of tightly coupled intact mitochondria
(Fig. 5). However, these effects are smaller than
those promoted by TAM, which induces disrup-
tion of the mitochondrial inner membrane integ-
Fig. 1. Effects of OHTAM on mitochondrial RCR (k) and
ADP/O (m) ratio. Mitochondria (1 mg) in 1 ml of the standard
respiratory medium supplemented with 2 mM rotenone were
incubated with different OHTAM concentrations for 3 min
prior to succinate addition (state 4). After 2 min of energiza-
tion, mitochondria were supplemented with ADP (150 nmol/mg
protein) to induce state 3 conditions. Mitochondrial respiration
rates were determined by O2 consumption using a Clark-type
electrode. Both indexes were calculated as described in Section
2. The results are means9/SD of four independent experiments.
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rity, as evidenced in Fig. 5 and further in Fig. 8
and Fig. 9.
To clarify the mechanisms responsible for the
stimulation of state 4 respiration and DC depolar-
ization, the effects of OHTAM on mitochondria
were evaluated according to the approach devel-
oped by Brand (1990) (Fig. 6). This approach has
been pointed to be useful to determine how
compounds of pharmacological interest affect the
mitochondria (Fusi et al., 1992). Nonphosphory-
lating mitochondria (in the presence of oligomy-
cin) were titrated with FCCP to promote an
increase in respiratory rate and a decrease in DC.
The plot of DC versus respiration rate describes
the kinetic response of the Dp generators to DC
(Brand, 1990) (Fig. 6). If a compound inhibits the
respiratory chain, this curve will be displaced
downward and to the left (Brand, 1990). Fig. 6
shows DC changes versus the respiration rate
obtained in the absence (control) and in the
presence of several concentrations of OHTAM
(20, 40 and 60 nmol OHTAM/mg protein). At any
given value of DC, OHTAM induces a slight
decrease in the respiration rate. The displacement
of the curve induced by OHTAM indicates that
one or more components of the Dp generat-
ing system are slightly inhibited by this drug, in
contrast with the severe effects induced by TAM
on the respiratory chain (Cardoso et al., 2001).
The putative proton leaks induced by OHTAM
through the mitochondrial inner membrane were
investigated in nonphosphorylating mitochondria
titrated with malonate, a respiratory inhibitor, and
DC was plotted versus respiration rate (Fig. 7). In
the steady state, the proton efflux must equal the
proton leak, assuming that no slip in the proton
pump occurs (Murphy, 1989) and any secondary
effects on the leak due to alterations in the Dp
value were eliminated. When a compound in-
creases the proton leak across the mitochondrial
Fig. 2. Effect of OHTAM on mitochondrial transmembrane potential (DC). Mitochondria (1 mg) incubated for 3 min in 1 ml standard
respiratory medium supplemented with 2 mM rotenone and 4 mM TPP were energized with succinate after incubation at 25 8C for 3
min in the absence (control) and presence of different OHTAM concentrations (nmol/mg protein) indicated by the numbers adjacent to
the traces. Addition of ADP (150 nmol/mg protein) induces state 3 conditions. DC was determined using a TPP-sensitive electrode as
described in Section 2. The traces represent typical recordings from four to six experiments with different mitochondrial preparations.
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inner membrane, the curve will be displaced
downward and to the right (Brand, 1990). Accord-
ingly, OHTAM increases the proton leak across
the mitochondrial inner membrane (Fig. 7) since at
any given DC value the respiration rate is greater
in the presence of the antiestrogen to balance the
back flow of protons across the mitochondrial
inner membrane. It is noteworthy that the OH-
TAM-induced membrane permeabilization to pro-
tons is lower than that induced by TAM,
according to its effects on biomembranes, as
previously reported (Custo´dio et al., 1996; Cruz
Silva et al., 2001). Actually, in the presence of 20
nmol TAM/mg protein, the respiratory rate of
mitochondria to sustain /190 mV is about 32
nmol O2/min/mg protein, a value about 3 times
higher than that observed at the same concentra-
tion of OHTAM and similar to that induced by 60
nmol OHTAM/mg protein (Fig. 7).
In order to clarify whether the proton permea-
bilization is a consequence of either mitochondrial
membrane disruption or proton shuttling, the
effects of OHTAM on the integrity of the mito-
chondrial membrane of intact non-energized mi-
tochondria were evaluated. OHTAM causes a
Fig. 3. Effects of OHTAM and TAM on pH changes associated with ATP synthesis. The ATP synthesis was evaluated at 25 8C in 2
ml of reaction medium containing 130 mM sucrose, 50 mM KCl, 2.5 mM MgCl2, 5 mM KH2PO4, 0.5 mM HEPES, 0.1 mM EGTA
(pH 7.2), supplemented with 2 mM rotenone and 200 nmol ADP. Mitochondria (1 mg) were incubated for 3 min in the absence (a) and
presence of 20 (b), 40 (c) and 50 (d) nmol OHTAM/mg protein or 50 nmol TAM/mg protein (e). The reactions were started by adding 5
mM succinate and were monitored by following the consumption of protons with a pH electrode. The traces are typical of four
different experiments.
Fig. 4. Effect of sequential additions of OHTAM on DC (k)
and state 4 respiration (m) in non-phosphorylating mitochon-
dria. Mitochondria (1 mg) were suspended in 1 ml of the
standard respiratory medium supplemented with nigericin (50
ng/mg protein), oligomycin (1 mg/ml), 2 mM rotenone and 4 mM
TPP at 25 8C and were energized with 5 mM succinate.
Mitochondrial respiration rates and DC were evaluated simul-
taneously using a Clark-type electrode and a TPP selective
electrode, respectively, placed in the same reaction chamber.
After steady-state distribution of TPP, the mitochondrial
suspension was titrated with sequential additions of 10 nmol
OHTAM/mg protein. The results are means9/SD of three
separate experiments with different mitochondrial preparations.
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small dose-dependent decrease in the light scatter-
ing of non-energized mitochondria in suspension
(Fig. 8), reflecting a slight direct effect of this drug
on mitochondrial membrane integrity. Such effect
becomes more evident at OHTAM proportions
above 40 nmol/mg mitochondrial protein, suggest-
ing that this drug only at high concentrations may
interfere with the integrity of mitochondrial mem-
branes, perturbing their permeability. However,
these effects are not significant relatively to those
induced by TAM, which at 50 nmol/mg protein
causes an extensive swelling of mitochondria. The
assessment of mitochondria integrity was further
confirmed by using the accessibility of citrate
synthase from matrix to oxaloacetic acid through
the mitochondrial membrane (Fig. 9). According
to that observed in mitochondrial swelling studies
(Fig. 8), increasing concentrations of OHTAM
induce relative slight effects on mitochondrial
integrity, since proportions of 10, 25 and 50
nmol/mg protein only affect 13, 17 and 40% of
mitochondria, respectively. In contrast, TAM at
concentrations of 25 and 50 nmol/mg protein
disrupts 66 and 80% of the mitochondrial popula-
tion, respectively, pointing out that this anticancer
drug induces a much stronger disruptive effect on
the mitochondrial membrane structure (Fig. 9).
The concentrations of OHTAM usually reached
in blood plasma after therapeutic administration
are about 3/5 ng/ml (Lien et al., 1987; McCague et
al., 1990), although recently it has been reported
that OHTAM attained in rat serum a Cmax of
3859/132 ng/ml (0.9 mM) after s.c. administration
of a second dose of TAM at 1 mg/kg (Mandlekar
et al., 2000). Owing to its high hydrophobic
character and partition into biological membranes
(Custo´dio et al., 1991), the levels of OHTAM in
humans are 10- to 60-fold higher in tissues than in
plasma (Lien et al., 1991). Therefore, the thera-
peutics with OHTAM may cause tissue concentra-
Fig. 5. Comparison of OHTAM and TAM effects on ATPase
of intact mitochondria. The ATPase activity was evaluated at
25 8C in 2 ml of reaction medium containing 130 mM sucrose,
50 mM KCl, 2.5 mM MgCl2, 5 mM KH2PO4, 0.5 mM HEPES,
0.1 mM EGTA (pH 7.2) and supplemented with 2 mM
rotenone. After pre-incubation of mitochondria (1 mg) for 3
min with different concentrations of OHTAM or TAM (nmol/
mg protein), as indicated by the values adjacent to the traces,
the reactions were started by adding 2 mM Mg-ATP and were
monitored by following the production of protons with a pH
electrode. Oligomycin (1 mg/mg protein) was added 1.5 min
after Mg-ATP addition. The traces are typical of three different
experiments.
Fig. 6. Effect of OHTAM on the kinetic response of Dp
generators to DC. Nonphosphorylating mitochondria (1 mg)
suspended in 1 ml of the standard respiratory medium
supplemented with nigericin (50 ng/mg protein), oligomycin (1
mg/ml), 2 mM rotenone and 4 mM TPP were incubated at
25 8C for 3 min in the absence (k) and presence of 20 (I), 40
(j) and 60 (m) nmol OHTAM/mg protein. Mitochondrial
respiration and DC were measured simultaneously with a
Clark-type O2 electrode and a TPP
 sensitive electrode,
respectively, and were placed in the same closed reaction
chamber. The reactions were started with 5 mM succinate
and after a steady-state distribution of TPP, mitochondrial
suspensions were titrated by sequential additions of FCCP (10
nM). The results are typical of six different experiments
performed with three different mitochondrial preparations.
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tions similar to those observed for TAM (/50
mM) since the partitioning of OHTAM into
membranes is significantly higher than that of
TAM (Custo´dio et al., 1991). However, it is
worthy of notice that, in this study we have also
used higher concentrations only to compare the
effects of this metabolite with those previously
reported for TAM (Cardoso et al., 2001).
4. Discussion
Mitochondria serve as sensors of the xenobiotic-
induced toxicity that ultimately leads to cellular
disassembly (Wallace and Starkov, 2000). Re-
cently, we have reported that TAM-induced
alteration of mitochondrial bioenergetic capacity
may be involved in its antiproliferative ER-inde-
pendent activity and side effects on different cells
types (Cardoso et al., 2001).
In the present study, we evaluated the effects of
OHTAM, recognized to be more active and
possessing several hundred times more affinity to
the ER than TAM, on mitochondrial bioenergetic
functions. As reported for TAM, OHTAM de-
presses the oxidative phosphorylation capacity of
liver mitochondria in a concentration-dependent
way, as deduced from a decrease of respiratory
coefficient and of the ADP/O ratio (Fig. 1), but
TAM has expressed much more potent effects
(Cardoso et al., 2001). Moreover, OHTAM
slightly depresses the mitochondrial DC (Fig. 2)
and the state 3 respiration (Figs. 1 and 2) but
induces stimulation of state 4 respiration (Fig. 4)
as a function of concentration that also reflect a
partial impairment of the phosphorylation effi-
ciency of mitochondria. However, as opposed to
TAM that promotes a strong inhibition of the
oxidative phosphorylation of added ADP, as
shown in Fig. 3 and also according to our previous
results (Cardoso et al., 2001), the phosphorylation
efficiency of mitochondria is not significantly
affected by OHTAM (Fig. 1). This is also inferred
from the fluctuations associated with the ADP-
induced phosphorylative cycle (Fig. 2) and from
the effects on pH changes associated with ATP
synthesis (Fig. 3).
Fig. 7. Effect of OHTAM on the proton leak of non-
phosphorylating mitochondria. Mitochondria were incubated
in the absence (k) and presence of 20 (I), 40 (j) and 60 (m)
nmol OHTAM/mg or 20 nmol TAM/mg protein for compar-
ison (\*/dashed line). Experiments were performed as de-
scribed in Fig. 6, except that mitochondria suspensions were
titrated by sequential additions of malonate, a respiratory
inhibitor. The results are representative of four independent
experiments.
Fig. 8. Effects of OHTAM and TAM on mitochondrial
swelling. The experiments were performed in 2 ml of reaction
medium containing 200 mM sucrose, 10 mM Tris-Mops (pH
7.4), 1 mM KH2PO4 and 10 mM EGTA. Mitochondria (0.5 mg/
ml) were incubated at 30 8C for 3 min in the absence (a) and
presence of 10 (b), 30 (c), 50 (d) nmol OHTAM/mg protein or
50 nmol TAM/mg protein (e). The traces, obtained by following
the light scattering at 540 nm, are typical of three separate
experiments with different mitochondrial preparations.
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The OHTAM-induced increase in the respira-
tory rate in state 4 that parallels the partial
collapse of the DC (Fig. 4) and the decrease of
the ADP phosphorylation indicate an uncoupling
effect of this drug on the oxidative phosphoryla-
tion system. The observed partial uncoupling
effect observed is probably due to a slight permea-
bilization of the mitochondrial inner membrane to
protons as confirmed by the Brand approach (Fig.
7). This effect could be related with a protono-
phoretic action and/or a nonspecific membrane
permeabilization induced by this tertiary-amine
antiestrogen (Murphy, 1989). In fact, a proton
shuttle mechanism has been proposed to explain
the ability of some tertiary-amine local anesthetics
and other amine compounds to uncouple oxida-
tion from phosphorylation (Garlid and Naka-
shima, 1983). Similarly, this mechanism could
also explain the uncoupling effect of OHTAM,
since the amine group of this drug can bind and
translocate protons across the mitochondrial inner
membrane due to its high lipophilic character and
strong partition into biomembranes (Custo´dio et
al., 1991). Moreover, the charged protonated form
of OHTAM, preferentially located in the outer
regions of the bilayer (Custo´dio et al., 1993), could
be membrane-permeable and determine the in-
crease in proton leak, acting in low concentrations
like a classic protonophore. In addition to its
uncoupling effect, the ionizable group of OH-
TAM, by changing the membrane surface poten-
tial, may induce a nonspecific inhibition of the
phosphorylation system and a specific inhibition
of either the adenine nucleotide translocator or the
phosphate transporter. Further studies, currently
in progress, are obviously required to assess these
hypotheses focused on the membrane transporters.
Both suggestions could explain the decrease in the
oxidative phosphorylation capacity and the partial
collapse of the DC due to proton leak that
parallels the stimulation of state 4 respiration
rate (Fig. 4), as previously reported for several
lipophilic compounds possessing base- or acid-
dissociative groups (Garlid and Nakashima, 1983;
Fromenty et al., 1990; Keller et al., 1992). How-
ever, it cannot be excluded that the uncoupling
action of OHTAM, at high concentrations, might
be due to a nonspecific increase in the membrane
permeability as a consequence of the mitochon-
drial membrane disruption.
To assess the relationship between the proton
leak and ultrastructural changes induced by OH-
TAM, the stimulated ATPase activity was mea-
sured in intact mitochondria pre-incubated with
this drug (Fig. 5). Furthermore, the OHTAM
effects on mitochondrial swelling (Fig. 8) and on
the citrate synthase activity of intact mitochondria
(Fig. 9) were also evaluated. OHTAM at high
concentrations stimulates ATPase activity of in-
tact mitochondria, but to a smaller degree than
FCCP or TAM (Fig. 5) which induces membrane
disruption as previously described (Chen et al.,
1999; Cruz Silva et al., 2000; Cardoso et al., 2001).
Moreover, the decrease in light scattering of non-
energized mitochondria (Fig. 8) and the stimula-
tion of citrate synthase (Fig. 9) induced by
OHTAM, together with the previous data demon-
strating the release of Ca2 by SR (Custo´dio et al.,
Fig. 9. Comparison of OHTAM and TAM effects on citrate
synthase activity of intact mitochondria. The citrate synthase
activity was measured in 2 ml of reaction medium containing
100 mM Tris (pH 8) and supplemented with 200 mM 5,5?-dithio-
bis(2-nitrobenzoic acid) and 200 mM acetylCoA. After incuba-
tion of mitochondria (100 mg) at 30 8C for 3 min in the absence
(a) and presence of either 10 (b), 25 (c), 50 (d) nmol OHTAM/
mg protein, or 25 (e) and 50 (f) nmol TAM/mg protein or 0.1%
Triton (g), the reactions were started by adding 100 mM
oxaloacetic acid. The citrate synthase activity expressed in
mmol/min/mg protein, as indicated by the values adjacent to the
traces, was followed by the increase in absorbance at 412 nm as
function of time. The recordings are representative of four
different mitochondrial preparations.
C.M.P. Cardoso et al. / Toxicology 179 (2002) 221/232230
1996) and of K from erythrocytes (Cruz Silva et
al., 2001), point to the membrane permeabilization
ability of this drug. Therefore, at low concentra-
tions OHTAM may promote membrane permea-
bilization to protons by acting as a proton shuttle,
whereas TAM has showed to induce a much more
potent proton leak (Fig. 7). At high concentra-
tions, OHTAM partially uncouples oxidative
phosphorylation due to a slight permeabilization
related with the disruption of the structural
integrity of the mitochondrial inner membrane.
Besides the increase in the membrane permeability
to protons, the inhibition of respiration induced by
this drug at high concentrations (Fig. 6) may
contribute to the understanding of the mechanism
underlying its depressive effect on DC.
In conclusion, our results suggest that OHTAM
slightly affects the mitochondrial bioenergetic
functions, inducing a partial uncoupling of the
oxidative phosphorylation system, in contrast with
the deleterious effects of TAM in rat liver mito-
chondria (Cardoso et al., 2001). The low depres-
sive effect of OHTAM on DC may activate the
apoptotic machinery of cytochrome c release,
leading to induction of caspase-dependent apop-
tosis. Moreover, these data indicate that OHTAM
is much less toxic to mitochondria than TAM, in
agreement with the different effects of both drugs
in human erythrocytes (Cruz Silva et al., 2000,
2001) and with the different apoptotic effects in
p53(/) human mammary epithelial cells (Dietze et
al., 2001).
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